52
Participants
Start Date
October 23, 2018
Primary Completion Date
October 26, 2019
Study Completion Date
June 12, 2020
CPX-351
VYXEOS is administered as an intravenous (IV) infusion over approximately 90 minutes.
University of Maryland, Baltimore
Wake Forest University School of Medicine, Winston-Salem
Franciscan Physician Network Oncology and Hematology Specialists, Indianapolis
Washington University School of Medicine, St Louis
University of Kansas Medical Center, Westwood
Tulane University Hospital & Clinic, New Orleans
Ochsner Clinic Foundation, New Orleans
Lead Sponsor
Jazz Pharmaceuticals
INDUSTRY